Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overview of Atopic Dermatitis in Different Ethnic Groups
Andrea Chiricozzi, Martina Maurelli, Laura Calabrese, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 7, pp. 2701-2701
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Update on the pathogenesis of atopic dermatitis
Paulo Ricardo Criado, Hélio Amante Miot, Roberto Bueno Filho, et al.
Anais Brasileiros de Dermatologia (2024) Vol. 99, Iss. 6, pp. 895-915
Open Access | Times Cited: 5
Roads to remission: evolving treatment concepts in type 2 inflammatory diseases
Marek Lommatzsch, Katharina Blümchen, Lisa A. Beck, et al.
EClinicalMedicine (2025) Vol. 80, pp. 103050-103050
Open Access
Interleukin-23 versus Interleukin-17 Inhibitors in Preventing Incidental Psoriatic Arthritis in Patients with Psoriasis: A Real-World Comparison From the TriNetX US Collaborative Network
Sebastian Yu, An‐Ping Huo, Yu‐Hsun Wang, et al.
BioDrugs (2025)
Open Access
Clinical Characteristics of Atopic Dermatitis Across Racial and Ethnic Groups: A Systematic Review
Darshana Seeburruth, Nicholas Hua, Ragav Chona, et al.
Journal of Cutaneous Medicine and Surgery (2025)
Closed Access
Filaggrinopathies—FLG/FLG2: Diagnostic Complexities and Immunotherapy
Zahra Nouri, Sajjad Biglari, Mohammad Amin Tabatabaiefar, et al.
Journal of Investigative Dermatology (2025)
Closed Access
Pathogenesis and management of atopic dermatitis: insights into epidermal barrier dysfunction and immune mechanisms
Anurag T. K. Baidya, Ulaganathan Mabalirajan
(2025)
Open Access
Interleukin-4 and Atopic Dermatitis: Why Does it Matter? A Narrative Review
Tiago Torres, Pedro Mendes‐Bastos, Maria João Cruz, et al.
Dermatology and Therapy (2025)
Open Access
Efficacy and Safety of 611 in Chinese Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Phase II Trial
Yan Zhao, Litao Zhang, Liming Wu, et al.
Dermatology and Therapy (2025)
Open Access
Effectiveness and Safety of Tralokinumab in Atopic Dermatitis: 1-year Results From a Real-world Multicentre Study
Laura Marina Calabrese, Élisa Cinotti, Martina D’Onghia, et al.
Acta Dermato Venereologica (2025) Vol. 105, pp. adv42275-adv42275
Open Access
Local allergic rhinitis in Asia: rethinking the allergy landscape
Aneeza Khairiyah Wan Hamizan, Salina Husain, Pongsakorn Tantilipikorn
Current Opinion in Allergy and Clinical Immunology (2025)
Closed Access
Global, regional, and national burden of older adult atopic dermatitis in 204 countries and territories worldwide
Yi Ou, Xinyi Shao, Jingbo Zhang, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Atopic Dermatitis in the Elderly Population
Martina Maurelli, Andrea Chiricozzi, Ketty Peris, et al.
Acta Dermato Venereologica (2023) Vol. 103, pp. adv13363-adv13363
Open Access | Times Cited: 12
Coffea arabica Extract Attenuates Atopic Dermatitis-like Skin Lesions by Regulating NLRP3 Inflammasome Expression and Skin Barrier Functions
Qiao-Xin Chang, Jia-Ling Lyu, Po‐Yuan Wu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12367-12367
Open Access | Times Cited: 9
Biomarkers in Atopic Dermatitis
Florence Libon, Juliette Caron, Arjen Nikkels
Dermatology and Therapy (2024) Vol. 14, Iss. 7, pp. 1729-1738
Open Access | Times Cited: 3
Diseases from the Spectrum of Dermatitis and Eczema: Can “Omics” Sciences Help with Better Systematics and More Accurate Differential Diagnosis?
Radosław Śpiewak
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10468-10468
Open Access | Times Cited: 8
Efficacy and Safety of Crisaborole Ointment 2% in Chinese Patients Aged ≥ 2 Years with Mild to Moderate Atopic Dermatitis
Lin Ma, Xiaohua Tao, Sujun Liu, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 5, pp. 1229-1243
Open Access | Times Cited: 2
Blocking the IL-4/IL-13 Axis versus the JAK/STAT Pathway in Atopic Dermatitis: How Can We Choose?
Laura Marina Calabrese, Martina D’Onghia, Laura Lazzeri, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 7, pp. 775-775
Open Access | Times Cited: 2
Genomic, Epigenomic, Transcriptomic, Proteomic and Metabolomic Approaches in Atopic Dermatitis
Dalia Bratu, Daniel Boda, Constantin Căruntu
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 6, pp. 5215-5231
Open Access | Times Cited: 6
Inflammatory dermatoses in children and adolescents
Kira Süßmuth, Nina Magnolo, Vinzenz Oji, et al.
Deleted Journal (2024) Vol. 75, Iss. 4, pp. 325-339
Closed Access | Times Cited: 1
Revolutionizing the management of patients with atopic dermatitis: practical considerations
Filomena Russo, Anna Rita Giampetruzzi, Maria Pilla, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 4, pp. 213-215
Open Access | Times Cited: 1
Kahweol Inhibits Pro-Inflammatory Cytokines and Chemokines in Tumor Necrosis Factor-α/Interferon-γ-Stimulated Human Keratinocyte HaCaT Cells
Ye Jin Kwon, Hyun Hee Kwon, Jaechan Leem, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 4, pp. 3470-3483
Open Access | Times Cited: 1
Anti-Atopic Dermatitis Effect of TPS240, a Novel Therapeutic Peptide, via Suppression of NF-κB and STAT3 Activation
Dongwoo Lee, Jeon Hwang‐Bo, Karpagam Veerappan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15814-15814
Open Access | Times Cited: 4
Race science without racists: how bigoted paradigms persist in allergy research
Ian A. Myles
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
Mutacii 2282del4, R501X, R2447X, S3247X fillagrina pri atopicheskom dermatite
Dmitry A. Verbenko, Arfenya Е. Karamova, В. В. Чикин, et al.
Вестник Российского государственного медицинского университета (2024), Iss. 2024(1)
Open Access
Cost per responder analysis of abrocitinib versus dupilumab in moderate to severe atopic dermatitis
Martina Maurelli, Giampiero Girolomoni, Paolo Gisondi
Italian Journal of Dermatology and Venereology (2024) Vol. 159, Iss. 6
Closed Access
Page 1 - Next Page

Scroll to top